Published: 2022-08-25

Clinical practice for the management of atopic dermatitis (eczema) patients attending dermatology outpatient department at a tertiary health care centre

N. L. Sirisha, Shaik Kareemulla, K. Charitha, S. Reddemma, B. Veera Kumar, A. Sreeja


Background: Atopic dermatitis (AD) is a chronic pruritic inflammatory skin condition that affects all age groups. It is one of the most common skin disorders in developed countries. Symptoms are eczematous papules, itch and associated consequences, like sleep disturbances that significantly have an impact on quality of life of the patients. The standard therapies for AD consist of the use of topical corticosteroids, topical applications of emollients, and oral formulations. The present study was undertaken with a view to find out the treatment patterns for AD in patients visited dermatology outpatient department (OPD) in a tertiary care teaching hospital.

Methods: A prospective observational study conducted for a period of three months at OPD of dermatology in tertiary care hospital (GGH-RIMS), Kadapa. A total of 45 prescriptions were collected after obtaining a proper informed consent from recruited patients.

Results: In a total of 45 prescriptions analysis, it was found that there was a female predominance with a female to male ratio of 2:1. AD was more prevalent in the age group of 20-29 years. Topical preparations were highly prescribed i.e., 90 utilizations when compared to oral formulations having 60 utilizations. Levocetirizine was the most commonly prescribed drug.

Conclusions: This study provides prescription patterns of AD in a tertiary care hospital. Cost can be minimized by generic prescribing. Treatment strategies to be individualized having strong emphasis on patient education. Self-management strategies also optimize outcomes and reduces unnecessary costs associated with management of AD.


Atopic dermatitis, Predominance, Prescription patterns, Antihistamines, Emollients

Full Text:



Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014;71(6):1218-33.

Lee JH, Son SW, Cho SH. A Comprehensive Review of the Treatment of Atopic Eczema. Allergy Asthma Immunol Res. 2016;8(3):181-90.

Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The Burden of Atopic Dermatitis: Summary of a Report for the National Eczema Association. J Invest Dermatol. 2017;137(1):26-30.

Thomsen SF. Atopic dermatitis: Natural history, diagnosis, and treatment. Int Sch Res Notices. 2014;354250.

Lee JH, Kim JE, Park GH, Bae JM, Byun JY, Shin MK, et al. Consensus update for systemic treatment of Atopic Dermatitis. Ann Dermatol. 2021;33(6):497-514.

Kim, BS, Howell, MD, Sun K, Papp K, Nasir A, Kuligowski, ME. Treatment of atopic dermatitis with Ruxolitinib cream (JAK1/JAK2 inhibitor) or Triamcinolone cream. J Allergy Clin Immunol. 2020;145(2):572-82.

Hanifin JM, Reed ML. A population-based survey of eczema prevalence in the United States. Dermatitis. 2007;18(2):82-91.

Kumar MK, Singh PK, Patel PK. Clinico-immunological profile and their correlation with severity of atopic dermatitis in Eastern Indian children. J Nat Sci Biol Med. 2014;5(1):5-100.

Sharma P, Kapoor B. Study of prescribing pattern for rational drug therapy. JK Science. 2003;5(3):107-9.

Arndt J, Smith N, Tausk F. Stress and atopic dermatitis. Curr Allergy Asthma Rep. 2008;8(4):312-7.

Rajagopalan M, De A, Godse K, Krupa Shankar DS, Zawar V, Sharma N et al. Guidelines on management of atopic dermatitis in India: An evidence-based review and an expert consensus. Indian J Dermatol. 2019;64(3):166-81.

Bunikowski R, Mielke M, Skarabis H, Worm M, Anagnostopoulos I, Kolde G, et al. Evidence for disease promoting effect of Staphylococcus aureus-derived exotoxins in eczema. J Allergy Clin Immunol. 2000;105(4):814-9.

Tikoo D, Chopra SC, Kaushal S, Dogra A. Evaluation of drug use pattern in dermatology as a tool to promote rational prescribing. JK science. 2011;13(3):128-31.

Loden M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol 2003;4(11):771-88.